Infect Chemother.  2015 Sep;47(3):167-174. 10.3947/ic.2015.47.3.167.

Detection of Carbapenemases in Clinical Enterobacteriaceae Isolates Using the VITEK AST-N202 Card

• Bae IK
• Kang HK
• Jang IH
• Lee W
• Kim K
• Kim JO
• Jeong SH
• Lee K

• KMID: 2068981
• DOI: http://doi.org/10.3947/ic.2015.47.3.167

Abstract

BACKGROUND
The rapid and accurate detection of carbapenemase-producing Enterobacteriaceae (CPE) in clinical microbiology laboratories is essential for the treatment and control of infections caused by these microorganisms. This study was performed to evaluate the ability of the VITEK AST-N202 card to detect CPE isolates.
MATERIALS AND METHODS
A total of 43 (Klebsiella pneumoniae, n = 37; Escherichia coli, n = 3; and Enterobacter cloacae, n = 3) CPE isolates and 79 carbapenemase-non-producing Enterobacteriaceae (CNE) isolates were included in this study. The CPE isolates harbored KPC-2 (n = 11), KPC-3 (n = 20), GES-5 (n = 5), VIM-2 (n = 2), IMP-1 (n = 1), NDM-1 (n = 2), or OXA-232 (n = 2). Of the 79 CNE isolates, eight K. pneumoniae isolates were resistant to ertapenem, imipenem, and meropenem, while the remaining 71 isolates were susceptible to the carbapenems. Antimicrobial susceptibilities were tested using the VITEK AST-N202 card, and the results were interpreted as positive when the isolates showed resistant or intermediate results. Modified-Hodge tests (MHTs) were performed using ertapenem or meropenem disks for the screening of carbapenemase production. Polymerase chain reaction (PCR) and direct sequencing were used to identify beta-lactamase genes.
RESULTS
Sensitivity of MHT with ertapenem and meropenem disks for the detection of carbapenemase was 81.4% (35/43) and 81.4% (35/43), respectively, and a combination with both antibiotic disks increased the sensitivity to 88.4% (38/43). Specificity of the MHT was 100% (79/79) for the CNE isolates. Sensitivity of ertapenem, imipenem, and meropenem as assessed by the VITEK AST-N202 card was 100% (43/43), 93% (40/43), and 95.3% (41/43), respectively. Specificity (89.8%, 71/79) of the test with each carbapenem was improved to 100% (71/71) when eight carbapenem-resistant CNE isolates were excluded from the testing.
CONCLUSION
The VITEK AST-N202 card showed high sensitivity for the detection of carbapenemases in Enterobacteriaceae strains. PCR and sequencing experiments for the detection of carbapenemases are recommended when clinical Enterobacteriaceae isolates show non-susceptibility to carbapenems.

Keyword

Carbapenemase-producing Enterobacteriaceae; VITEK AST-N202 card; KPC; GES; NDM

MeSH Terms

beta-Lactamases
Carbapenems
Enterobacter cloacae
Enterobacteriaceae*
Escherichia coli
Imipenem
Mass Screening
Pneumonia
Polymerase Chain Reaction
Sensitivity and Specificity
Carbapenems
Imipenem
beta-Lactamases

Reference

1. Bergogne-Bérézin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996; 9:148–165.

2. Gehrlein M, Leying H, Cullman W, Wendt S, Opferkuch W. Imipenem resistance in Acinetobacter baumannii is due to altered penicillin binding proteins. Chemotherapy. 1991; 37:405–412.

3. Urban C, Go E, Mariano N, Rahal JJ. Interactions of sulbactam, clavulanic acid and tazobactam with penicillin binding proteins of imipenem-resistant and susceptibile Acinetobacter baumannii. FEMS Microbiol Lett. 1995; 125:193–197.

4. Clark RB. Imipenem resistance among Acinetobacter baumannii association with reduced expression of a 33-36 kDa outer membrane protein. J Antimicrob Chemother. 1996; 38:245–251.

5. Walsh TR. Emerging carbapenemase: a global perspective. Int J Antimicrob Agents. 2010; 36:Suppl 3. S8–S14.

6. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011; 17:1791–1798.

7. Carrër A, Frotineau N, Nordmann P. Use of ChromID extended-spectrum β-lactamase medium for detecting carbapenemase-producing Enterobacteriaceae. J Clin Microbiol. 2010; 48:1913–1914.

8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-three informational supplement (M100-S23). Wayne, PA, USA: CLSI;2013.

9. Bae IK, Jang SJ, Kim J, Jeong SH, Cho B, Lee K. Interspecies dissemination of the bla gene encoding PER-1 extended-spectrum β-lactamase. Antimicrob Agents Chemother. 2011; 55:1305–1307.

10. Tam VH, Chang KT, Abdelraouf K, Brioso CG, Ameka M, McCaskey LA, Western JS, Caeiro JP, Garey KW. Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2010; 54:1160–1164.

11. Park KO, Son HC, Bae IK, Jeong SH. Molecular epidemiology of infection caused by OXA-23 or IMP-1 β-lactamase-producing Acinetobacter baumannii. Korean J Clin Microbiol. 2005; 8:121–129.

12. Bae IK, Lee YN, Jeong SH, Lee K, Yong D, Lee J, Hong SG, Park YJ, Choi TY, Uh Y, Shin JH, Lee WG, Ahn JY, Lee SH, Woo GJ, Kwak HS. Emergence of CTX-M-12, PER-1 and OXA-30 β-lactamase-producing Klebsiella pneumoniae. Korean J Clin Microbiol. 2006; 9:102–109.

13. Rhee JY, Park YK, Shin JY, Choi JY, Lee MY, Peck KR, Song JH, Ko KS. KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea. Antimicrob Agents Chemother. 2010; 54:2278–2279.

14. Roh KH, Lee CK, Sohn JW, Song W, Yong D, Lee K. Isolation of a Klebsiella pneumoniae isolate of sequence type 258 producing KPC-2 carbapenemase in Korea. Korean J Lab Med. 2011; 31:298–301.

15. Yoo JS, Kim HM, Yoo JI, Yang JW, Kim HS, Chung GT, Lee YS. Detection of clonal KPC-2-producing Klebsiella pneumoniae ST258 in Korea during nationwide surveillance in 2011. J Med Microbiol. 2013; 62:1338–1342.

16. Hong SK, Yong D, Kim K, Hong SS, Hong SG, Khosbayar T, Song W, Roh KH, Jeong SH, Lee K, Chong Y. First outbreak of KPC-2-producing Klebsiella pneumoniae sequence type 258 in a hospital in South Korea. J Clin Microbiol. 2013; 51:3877–3879.

17. Lee Y, Kim BS, Chun J, Yong JH, Lee YS, Yoo JS, Yong D, Hong SG, D'Souza R, Thomson KS, Lee K, Chong Y. Clonality and resistome analysis of KPC-producing Klebsiella pneumoniae strain isolated in Korea using whole genome sequencing. Biomed Res Int. 2014; 2014:352862.

18. Ryoo NH, Kim EC, Hong SG, Park YJ, Lee K, Bae IK, Song EH, Jeong SH. Dissemination of SHV-12 and CTX-M-type extended-spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J Antimicrob Chemother. 2005; 56:698–702.

19. Jeong SH, Bae IK, Kim D, Hong SG, Song JS, Lee JH, Lee SH. First outbreak of Klebsiella pneumoniae clinical isolates producing GES-5 and SHV-12 extended-spectrum β-lactamases in Korea. Antimicrob Agents Chemother. 2005; 49:4809–4810.

20. Kim J, Hong SG, Bae IK, Kang JR, Jeong SH, Lee W, Lee K. Emergence of Escherichia coli sequence type ST131 carrying both the bla_GES-5 and bla_CTX-M-15 genes. Antimicrob Agents Chemother. 2011; 55:2974–2975.

21. Yum JH, Yong D, Lee K, Kim HS, Chong Y. A new integron carrying VIM-2 metallo-β-lactamase gene cassette in a Serratia marcescens isolate. Diagn Microbiol Infect Dis. 2002; 42:217–219.

22. Jeong SH, Lee K, Chong Y, Yum JH, Lee SH, Choi HJ, Kim JM, Park KH, Han BH, Lee SW, Jeong TS. Characterization of a new integron containing VIM-2, a metallo-β-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae. J Antimicrob Chemother. 2003; 51:397–400.

23. Lee Y, Choi H, Yum JH, Kang G, Bae IK, Jeong SH, Lee K. Molecualr mechanisms of carbapenem resistance in Enterobacter cloacae clinical isolates from Korea and clinical outcome. Ann Clin Lab Sci. 2012; 42:281–286.

24. Kim MN, Yong D, An D, Chung HS, Woo JH, Lee K, Chong Y. Nosocomial clustering of NDM-1-producing Klebsiella pneumoniae sequence type 340 strains in four patients at a South Korean tertiary care hospital. J Clin Microbiol. 2012; 50:1433–1436.

25. Jeong SH, Lee KM, Lee J, Bae IK, Kim JS, Kim HS, Song W. Clonal and horizontal spread of the bla_OXA-232 gene among Enterobacteriaceae in a Korean hospital. Diagn Microbiol Infect Dis. 2015; 82:70–72.

26. Yoo JS, Kim HM, Koo HS, Yand JW, Yoo JI, Kim HS, Park HK, Lee YS. Nosocomial transmission of NDM-1-producing Escherichia coli ST101 in a Korean Hospital. J Antimicrob Chemother. 2013; 68:2170–2172.